EQUASENS (EQS.PA) Stock Price & Overview

EPA:EQS • FR0012882389

Current stock price

34.9 EUR
-0.1 (-0.29%)
Last:

The current stock price of EQS.PA is 34.9 EUR. Today EQS.PA is down by -0.29%. In the past month the price decreased by -0.71%. In the past year, price decreased by -0.57%.

EQS.PA Key Statistics

52-Week Range30.55 - 53.7
Current EQS.PA stock price positioned within its 52-week range.
1-Month Range33.7 - 38.25
Current EQS.PA stock price positioned within its 1-month range.
Market Cap
529.433M
P/E
14.54
Fwd P/E
11.50
EPS (TTM)
2.40
Dividend Yield
3.46%

EQS.PA Stock Performance

Today
-0.29%
1 Week
-3.31%
1 Month
-0.71%
3 Months
-20.27%
Longer-term
6 Months -23.08%
1 Year -0.57%
2 Years -31.77%
3 Years -51.19%
5 Years N/A
10 Years N/A

EQS.PA Stock Chart

EQUASENS / EQS Daily stock chart

EQS.PA Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to EQS.PA. When comparing the yearly performance of all stocks, EQS.PA is a bad performer in the overall market: 84.42% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

EQS.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA. EQS.PA has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EQS.PA Earnings

Next Earnings DateMar 30, 2026
Last Earnings DateNov 5, 2025
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

EQS.PA Forecast & Estimates

6 analysts have analysed EQS.PA and the average price target is 54.06 EUR. This implies a price increase of 54.9% is expected in the next year compared to the current price of 34.9.

For the next year, analysts expect an EPS growth of 9.47% and a revenue growth 9.26% for EQS.PA


Analysts
Analysts83.33
Price Target54.06 (54.9%)
EPS Next Y9.47%
Revenue Next Year9.26%

EQS.PA Groups

Sector & Classification

Index Membership

EQS.PA Financial Highlights

Over the last trailing twelve months EQS.PA reported a non-GAAP Earnings per Share(EPS) of 2.4. The EPS decreased by -13.9% compared to the year before.


Income Statements
Revenue(TTM)224.73M
Net Income(TTM)36.26M
Industry RankSector Rank
PM (TTM) 16.13%
ROA 8.82%
ROE 15.77%
Debt/Equity 0.09
Chartmill High Growth Momentum
EPS Q2Q%0.43%
Sales Q2Q%7.39%
EPS 1Y (TTM)-13.9%
Revenue 1Y (TTM)4.45%

EQS.PA Ownership

Ownership
Inst Owners11.96%
Shares15.17M
Float4.89M
Ins Owners0.2%
Short Float %N/A
Short RatioN/A

About EQS.PA

Company Profile

EQS logo image Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );

Company Info

IPO: 2000-10-20

EQUASENS

5 Allee de Saint-Cloud

Villers-les-Nancy GRAND EST FR

Employees: 1271

EQS Company Website

EQS Investor Relations

Phone: 33383159595

EQUASENS / EQS.PA FAQ

What does EQUASENS do?

Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );


What is the stock price of EQUASENS today?

The current stock price of EQS.PA is 34.9 EUR. The price decreased by -0.29% in the last trading session.


Does EQS stock pay dividends?

EQUASENS (EQS.PA) has a dividend yield of 3.46%. The yearly dividend amount is currently 1.25.


What is the ChartMill rating of EQUASENS stock?

EQS.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Where is EQUASENS (EQS.PA) stock traded?

EQS.PA stock is listed on the Euronext Paris exchange.


What is the Price/Earnings (PE) ratio of EQUASENS (EQS.PA)?

The PE ratio for EQUASENS (EQS.PA) is 14.54. This is based on the reported non-GAAP earnings per share of 2.4 and the current share price of 34.9 EUR.


What is EQUASENS worth?

EQUASENS (EQS.PA) has a market capitalization of 529.43M EUR. This makes EQS.PA a Small Cap stock.